Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cyclophosphamide/doxorubicin/prednisone/rituximab/vincristine

Known as: Rituximab/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine, R-CHOP Regimen, Rituxan/CHOP 
An abbreviation for a chemotherapy combination that is used to treat non-Hodgkin lymphoma and mantle cell lymphoma and is being studied in the… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Purpose Rituximab (R) plus CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy is the standard of care in… Expand
Is this relevant?
Highly Cited
2015
Highly Cited
2015
PURPOSE Twenty percent of patients with follicular lymphoma (FL) experience progression of disease (POD) within 2 years of… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2013
Highly Cited
2012
Highly Cited
2012
PURPOSE Diffuse large B-cell lymphoma (DLBCL) is curable in 60% of patients treated with rituximab plus cyclophosphamide… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
PURPOSE Approximately 5% of diffuse large B-cell lymphomas (DLBCLs) are double-hit lymphomas (DHLs) with translocations of both… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
PURPOSE To address early and late treatment failures in older patients with diffuse large B-cell lymphoma (DLBCL), we designed a… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Mantle cell lymphoma (MCL) is characterized by a poor prognosis with a low to moderate sensitivity to chemotherapy and a… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Phase 2 studies suggest that the monoclonal antibody rituximab may improve the prognosis of patients with follicular lymphoma (FL… Expand
  • table 1
  • figure 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine… Expand
  • figure 1
  • figure 2
  • table 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine… Expand
Is this relevant?